![David Burke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Burke
Contatto Relazioni con gli Investitori presso
SERNOVA BIOTHERAPEUTICS INC
Profilo
David Burke currently works at The Ruth Group, Inc., as Vice President, The IGB Group, as Vice President, and Sernova Biotherapeutics, Inc., as Vice President-Investor Relations from 2024.
Mr. Burke also formerly worked at Albemarle Corp., as Director-Investor Relations from 2021 to 2022, Rigel Pharmaceuticals, Inc., as Director-Investor Relations & Communications from 2018 to 2021, Dynavax Technologies Corp., as Director-IR & Corporate Communications from 2018 to 2019, and Aldeyra Therapeutics, Inc., as Head-Investor Relations.
Mr. Burke received his undergraduate degree from the University of North Carolina at Chapel Hill.
Posizioni attive di David Burke
| Società | Posizione | Inizio |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Contatto Relazioni con gli Investitori | 11/10/2024 |
The IGB Group
 The IGB Group Miscellaneous Commercial ServicesCommercial Services Operates as an independent investor relations, advisory and strategic communications firm | Presidente | - |
The Ruth Group, Inc.
 The Ruth Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and public relations services | Corporate Officer/Principal | - |
Precedenti posizioni note di David Burke
| Società | Posizione | Fine |
|---|---|---|
| ALBEMARLE CORPORATION | Contatto Relazioni con gli Investitori | 01/05/2022 |
| RIGEL PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | 01/01/2021 |
| DYNAVAX TECHNOLOGIES CORPORATION | Contatto Relazioni con gli Investitori | 29/01/2019 |
| ALDEYRA THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - |
Formazione di David Burke
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
23
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Albemarle Corp.
 Albemarle Corp. Chemicals: SpecialtyProcess Industries Manufactures basic lithium compounds for energy storage, plastic materials and organometallic co-catalysts | Process Industries |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
The Ruth Group, Inc.
The Ruth Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and public relations services | Commercial Services |
The IGB Group
The IGB Group Miscellaneous Commercial ServicesCommercial Services Operates as an independent investor relations, advisory and strategic communications firm | Commercial Services |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
